These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 1591060)
21. Malignant melanoma treated with natural interferons alfa and beta and DAV. Nagatani T; Ichiyama S; Miyakawa K; Uchiyama M Eur J Cancer; 1992; 28A(10):1774. PubMed ID: 1389506 [No Abstract] [Full Text] [Related]
22. A low rate of central nervous system progression in a phase II trial of outpatient chemobiologic therapy with cisplatin, temozolomide, interleukin-2, and interferon alfa 2-B for metastatic malignant melanoma. Ready N; Aronson F; Wanebo H; Kennedy T Am J Clin Oncol; 2005 Oct; 28(5):479-84. PubMed ID: 16199988 [TBL] [Abstract][Full Text] [Related]
23. A promising interferon plus four-drug chemotherapy regimen for metastatic melanoma. Pyrhönen S; Hahka-Kemppinen M; Muhonen T J Clin Oncol; 1992 Dec; 10(12):1919-26. PubMed ID: 1280673 [TBL] [Abstract][Full Text] [Related]
25. Phase II study of temozolomide plus pegylated interferon-alpha-2b for metastatic melanoma. Hwu WJ; Panageas KS; Menell JH; Lamb LA; Aird S; Krown SE; Williams LJ; Chapman PB; Livingston PO; Wolchok JD; Houghton AN Cancer; 2006 Jun; 106(11):2445-51. PubMed ID: 16639739 [TBL] [Abstract][Full Text] [Related]
26. A phase II study of combined administration of dacarbazine and carboplatin with home therapy of recombinant interleukin-2 and interferon-alpha 2a in patients with advanced malignant melanoma. Ron IG; Mordish Y; Eisenthal A; Skornick Y; Inbar MJ; Chaitchik S Cancer Immunol Immunother; 1994 Jun; 38(6):379-84. PubMed ID: 8205559 [TBL] [Abstract][Full Text] [Related]
27. Chemoimmunotherapy with bleomycin, vincristine, lomustine, dacarbazine (BOLD) plus interferon alpha for metastatic melanoma: a multicentre phase II study. Punt CJ; van Herpen CM; Jansen RL; Vreugdenhil G; Muller EW; de Mulder PH Br J Cancer; 1997; 76(2):266-9. PubMed ID: 9231931 [TBL] [Abstract][Full Text] [Related]
28. Development of a biochemotherapy regimen with concurrent administration of cisplatin, vinblastine, dacarbazine, interferon alfa, and interleukin-2 for patients with metastatic melanoma. Legha SS; Ring S; Eton O; Bedikian A; Buzaid AC; Plager C; Papadopoulos N J Clin Oncol; 1998 May; 16(5):1752-9. PubMed ID: 9586888 [TBL] [Abstract][Full Text] [Related]
29. Randomized phase II study of temozolomide given every 8 hours or daily with either interferon alfa-2b or thalidomide in metastatic malignant melanoma. Danson S; Lorigan P; Arance A; Clamp A; Ranson M; Hodgetts J; Lomax L; Ashcroft L; Thatcher N; Middleton MR J Clin Oncol; 2003 Jul; 21(13):2551-7. PubMed ID: 12829675 [TBL] [Abstract][Full Text] [Related]
30. A phase II study of biochemotherapy for the treatment of metastatic malignant melanoma. Gibbs P; Iannucci A; Becker M; Allen J; O'Driscoll M; McDowell K; Williams P; Rosse P; Murphy J; Gonzalez R Melanoma Res; 2000 Apr; 10(2):171-9. PubMed ID: 10803718 [TBL] [Abstract][Full Text] [Related]
31. Combination of chemotherapy with interleukin-2 and interferon alfa for the treatment of metastatic melanoma. Richards JM; Gale D; Mehta N; Lestingi T J Clin Oncol; 1999 Feb; 17(2):651-7. PubMed ID: 10080611 [TBL] [Abstract][Full Text] [Related]
32. Experience with interferon alpha 2b combined with dacarbazine in the treatment of metastatic malignant melanoma. Falkson CI Med Oncol; 1995 Mar; 12(1):35-40. PubMed ID: 8542245 [TBL] [Abstract][Full Text] [Related]
33. Bleomycin, vincristine, lomustine and dacarbazine (BOLD) in combination with recombinant interferon alpha-2b for metastatic uveal melanoma. Kivelä T; Suciu S; Hansson J; Kruit WH; Vuoristo MS; Kloke O; Gore M; Hahka-Kemppinen M; Parvinen LM; Kumpulainen E; Humblet Y; Pyrhönen S Eur J Cancer; 2003 May; 39(8):1115-20. PubMed ID: 12736111 [TBL] [Abstract][Full Text] [Related]
34. Effects of interferon-alpha, verapamil and dacarbazine in the treatment of advanced malignant melanoma. Andersson R; Ake Hofer P; Riklund-Ahlström K; Henriksson R Melanoma Res; 2003 Feb; 13(1):87-91. PubMed ID: 12569290 [TBL] [Abstract][Full Text] [Related]
35. Phase II study of interferon alpha-2a and dacarbazine in advanced melanoma. Bajetta E; Negretti E; Giannotti B; Brogelli L; Brunetti I; Sertoli MR; Bernengo MG; Sofra MC; Maifredi G; Zumiani G Am J Clin Oncol; 1990 Oct; 13(5):405-9. PubMed ID: 2220660 [TBL] [Abstract][Full Text] [Related]
36. Chemoimmunohormonal therapy with carmustine, dacarbazine, cisplatin, tamoxifen, and interferon for metastatic melanoma: a prospective phase II study. Stein ME; Bernstein Z; Tsalic M; Drumea K; Steiner M; Sklar Z; Haim N Am J Clin Oncol; 2002 Oct; 25(5):460-3. PubMed ID: 12393984 [TBL] [Abstract][Full Text] [Related]
37. Randomized phase II trial of BCDT [carmustine (BCNU), cisplatin, dacarbazine (DTIC) and tamoxifen] with or without interferon alpha (IFN-alpha) and interleukin (IL-2) in patients with metastatic melanoma. Johnston SR; Constenla DO; Moore J; Atkinson H; A'Hern RP; Dadian G; Riches PG; Gore ME Br J Cancer; 1998 Apr; 77(8):1280-6. PubMed ID: 9579834 [TBL] [Abstract][Full Text] [Related]
39. Interferon-alpha 2a does not improve response or survival when combined with dacarbazine in metastatic malignant melanoma: results of a multi-institutional Australian randomized trial. Thomson DB; Adena M; McLeod GR; Hersey P; Gill PG; Coates AS; Olver IN; Kefford RF; Lowenthal RM; Beadle GF Melanoma Res; 1993 Apr; 3(2):133-8. PubMed ID: 8518552 [TBL] [Abstract][Full Text] [Related]
40. A phase II evaluation of all-trans-retinoic acid plus interferon alfa-2a in stage IV melanoma: a Southwest Oncology Group study. Sondak VK; Liu PY; Flaherty LE; Fletcher WS; Periman P; Gandara DR; Taylor SA; Balcerzak SP; Meyskens FL Cancer J Sci Am; 1999; 5(1):41-7. PubMed ID: 10188060 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]